Drawing directly from the mission of the School of Medicine, the focus of this initiative is to:
- Embrace a culture of innovation to promote discovery
- Facilitate dissemination of new knowledge through entrepreneurial pathways to advance basic medical knowledge and ultimately improve patient care
Friday, September 9, 2022, 2:00 PM
Room 214 Light Hall
“So you want to be an entrepreneur . . .”
Chuck Haines, Ph.D., CEO IDBiologics
So you think you want to be an entrepreneur… I am an entrepreneur, an eternal optimist struggling every day against long odds. I am lucky enough to have my dream job! But I also have to do many things that I dread – it comes with the territory. I am constantly rejected, but the rare successes are truly meaningful. If this still sounds interesting, I’m happy to tell you more about my journey from academia to a biotech startup.
IDBiologics was founded in 2017 to discover and develop human monoclonal antibodies for the prevention, treatment, and cure of infectious diseases.
Our innovative fully human monoclonal antibody platform enables rapid discovery and optimization of broad and potent therapeutic molecules.
Using this proprietary platform, IDBiologics has accumulated unparalleled breadth in isolating antibodies for infectious diseases, with lead candidate molecules to diverse targets moving forward in development.
This lecture takes place in-person on Friday, September 9, 2022, at 2:00 pm in 214 Light Hall.
Registration is required: Register Here!